Vir Biotechnology, Inc. Soared
Tue, Jan 26, 2021 at 05:30 PM
Vir Biotechnology, Inc. (VIR:NASDAQ) soared at $77.38, representing a gain of 74.3%. On Mon 25 Jan 21, VIR:NASDAQ touched a New 2-Week High of $44.39. The stock got featured on our News Catalysts scanner on Tue 26 Jan 21 at 08:42 AM in the 'BIOTECH' category. From Mon 11 Jan 21, the stock recorded 66.67% Up Days and 70.00% Green Days
About Vir Biotechnology, Inc. (VIR:NASDAQ)
Vir Biotechnology Inc is a clinical-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions.
Top 10 Gainers:
- GameStop Corp. (GME:NYSE), 92.71%
- Pitney Bowes Inc. (PBI:NYSE), 81.01%
- Vir Biotechnology, Inc. (VIR:NASDAQ), 74.32%
- Koss Corporation (KOSS:NASDAQ), 66.67%
- Live Ventures Incorporated (LIVE:NASDAQ), 56.5%
- Forward Industries, Inc. (FORD:NASDAQ), 49.04%
- U.S. Auto Parts Network, Inc. (PRTS:NASDAQ), 48.16%
- AIkido Pharma Inc. (AIKI:NASDAQ), 46.72%
- Vertex Energy, Inc. (VTNR:NASDAQ), 46.01%
- BIOLASE, Inc. (BIOL:NASDAQ), 44.23%